Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy CytomX Therapeutics (CTMX) stocks in Canada
Learn how to easily invest in CytomX Therapeutics stocks.
CytomX Therapeutics is a biotechnology business based in the US. CytomX Therapeutics stocks (CTMX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.08 – an increase of 8.61% over the previous week. CytomX Therapeutics employs 144 staff and has a trailing 12-month revenue of around $66.2 million.
How to buy shares in CytomX Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CTMX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in CytomX Therapeutics?
- Has coronavirus impacted CytomX Therapeutics shares?
- CytomX Therapeutics shares summary
- Compare share dealing platforms
- Is CytomX Therapeutics stock a buy or sell?
- CytomX Therapeutics performance over time
- CytomX Therapeutics's financials
- How volatile are CytomX Therapeutics shares?
- Does CytomX Therapeutics pay a dividend?
- Other common questions
CytomX Therapeutics stock price (NASDAQ:CTMX)Use our graph to track the performance of CTMX stocks over time.
CytomX Therapeutics shares at a glance
|Latest market close||$4.29|
|52-week range||$3.67 - $10.05|
|50-day moving average||$5.77|
|200-day moving average||$6.20|
|Wall St. target price||$12.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.21|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy CytomX Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
CytomX Therapeutics price performance over time
|1 week (2022-01-14)||8.61%|
|1 month (2021-12-18)||N/A|
|3 months (2021-10-22)||-19.66%|
|6 months (2021-07-22)||-23.80%|
|1 year (2021-01-22)||-35.49%|
|2 years (2020-01-22)||-41.79%|
|3 years (2019-01-22)||16.11|
|5 years (2017-01-20)||11.5|
CytomX Therapeutics financials
|Revenue TTM||$66.2 million|
|Gross profit TTM||$100.4 million|
|Return on assets TTM||-12.1%|
|Return on equity TTM||-90.25%|
|Market capitalisation||$257.7 million|
TTM: trailing 12 months
CytomX Therapeutics share dividends
We're not expecting CytomX Therapeutics to pay a dividend over the next 12 months.
CytomX Therapeutics share price volatility
Over the last 12 months, CytomX Therapeutics's shares have ranged in value from as little as $3.67 up to $10.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CytomX Therapeutics's is 0.5884. This would suggest that CytomX Therapeutics's shares are less volatile than average (for this exchange).
CytomX Therapeutics overview
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatment of squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma; BMS-986249, a CTLA-4 Probody therapeutic drug, which is in Phase I/II clinical trials for the treatment of metastatic melanoma; and BMS-986288, an anti-CTLA-4 Probody drug, which is in Phase I clinical trials for the treatment of solid tumors. It also develops CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, as well as CX-904, a conditionally activated epidermal growth factor receptor for the treatment of solid tumor. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc. , Bristol-Myers Squibb Company, ImmunoGen, Inc.
Stocks similar to CytomX Therapeutics
CytomX Therapeutics in the news
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
CytomX (CTMX) Gets FDA Nod to Begin Study in Solid Tumors
Frequently asked questions
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.